ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+42.22%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$2.31B
AUM Growth
+$2.31B
(+38%)
Cap. Flow
+$52.7M
Cap. Flow
% of AUM
2.28%
Top 10 Holdings %
Top 10 Hldgs %
73.05%
Holding
40
New
5
Increased
6
Reduced
13
Closed
6
Top Buys
| 1 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
$52M |
| 2 |
AMRN
Amarin Corp
AMRN
|
$50.3M |
| 3 |
ARRY
Array Biopharma Inc
ARRY
|
$48.8M |
| 4 |
MDCO
Medicines Co
MDCO
|
$43.7M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
$35.6M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$68.6M |
| 2 |
LOXO
Loxo Oncology, Inc
LOXO
|
$45.5M |
| 3 |
Ascendis Pharma
ASND
|
$21.8M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
$21.3M |
| 5 |
TG Therapeutics
TGTX
|
$19.5M |
Sector Composition
| 1 | Healthcare | 83.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $340M | 14.71% | 17,714,461 | – | – |
|
|
MRTX
2
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $283M | 12.24% | 3,862,500 -935,601 | -19% | -$68.6M |
|
|
3
Ascendis Pharma
ASND
$11.8B
| $211M | 9.14% | 1,795,000 -185,000 | -9% | -$21.8M |
|
|
AMRN
4
Amarin Corp
AMRN
$311M
| $166M | 7.18% | 8,000,000 +2,425,000 | +43% | +$50.3M |
|
5
Sarepta Therapeutics
SRPT
$1.78B
| $142M | 6.16% | 1,195,000 -80,000 | -6% | -$9.54M |
|
6
Amicus Therapeutics
FOLD
$2.34B
| $129M | 5.59% | 9,500,000 -625,000 | -6% | -$8.5M |
|
|
HZNP
7
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $106M | 4.57% | 4,000,000 -350,000 | -8% | -$9.25M |
|
|
ZGNX
8
DELISTED
Zogenix, Inc.
ZGNX
| $105M | 4.56% | 1,915,000 -60,000 | -3% | -$3.3M |
|
9
argenx
ARGX
$43.6B
| $105M | 4.53% | 840,000 -20,000 | -2% | -$2.5M |
|
10
Iovance Biotherapeutics
IOVA
$807M
| $100M | 4.33% | 10,530,862 +269,823 | +3% | +$2.57M |
|
|
11
BioMarin Pharmaceuticals
BMRN
$11.2B
| $99.5M | 4.3% | 1,120,000 -240,000 | -18% | -$21.3M |
|
|
TCDA
12
DELISTED
Tricida, Inc. Common Stock
TCDA
| $65.7M | 2.84% | 1,700,000 -50,000 | -3% | -$1.93M |
|
|
MYOK
13
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $52M | 2.25% | +1,000,000 | New | +$52M |
|
|
GBT
14
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $50.3M | 2.17% | 950,000 +600,000 | +171% | +$31.8M |
|
|
ARRY
15
DELISTED
Array Biopharma Inc
ARRY
| $48.8M | 2.11% | +2,000,000 | New | +$48.8M |
|
|
MDCO
16
DELISTED
Medicines Co
MDCO
| $43.7M | 1.89% | +1,562,000 | New | +$43.7M |
|
|
BDSI
17
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $39.4M | 1.7% | 7,424,867 +2,699,867 | +57% | +$14.3M |
|
18
Madrigal Pharmaceuticals
MDGL
$9.76B
| $38.8M | 1.68% | 310,000 +85,000 | +38% | +$10.6M |
|
|
19
Acadia Pharmaceuticals
ACAD
$4.38B
| $35.6M | 1.54% | +1,325,000 | New | +$35.6M |
|
20
Allogene Therapeutics
ALLO
$251M
| $29.8M | 1.29% | 1,128,594 +10 | +0% | +$264 |
|
21
Xenon Pharmaceuticals
XENE
$2.98B
| $24.4M | 1.05% | 2,400,000 | – | – |
|
22
Indaptus Therapeutics
INDP
$7.19M
| $18.3M | 0.79% | 2,500,000 | – | – |
|
23
Assembly Biosciences
ASMB
$190M
| $17.7M | 0.77% | 900,000 -100,000 | -10% | -$1.97M |
|
24
Pacira BioSciences
PCRX
$1.2B
| $15.2M | 0.66% | 400,000 | – | – |
|
25
Establishment Labs
ESTA
$1.2B
| $11.4M | 0.49% | 475,000 | – | – |
|